We hear it all the time: We know you want a single name that’s short, easy to say, easy to spell, memorable, globally marketable, and has an obvious meaning. Sure, you want to call your medication Cureitall or Bestlife, but the bad news is you can’t; even Kureitall and Beslyfe are off the table. The reality is that it’s simply not possible to check off all those boxes for a name while also protecting your intellectual property (IP) and getting approval from global regulatory bodies.
With that said, designing a name for an asset is more than picking something that sounds cool or obvious. There are constraints to work within, and those constraints are continuously evolving with every new name approval and trademark filing.
Moreover, you’ve likely invested significant resources into developing your product to improve the lives of patients. Your drug has undergone a gauntlet of efficacy and safety testing, and you’ve been committed to lab testing and clinical trial research to verify its viability. But you can’t bring your drug to market until you have a drug name that can survive the rigor of roadblocks and red flags. Sound overwhelming? A seasoned pharmaceutical naming agency will make it seem effortless.
Without a pharmaceutical naming agency and going at it internally, you will more than likely find yourself creating a name that is ultimately rejected. When this rejection brings you back to square one and delays your launch, it can potentially result in a daily loss of as much as $8 million in revenue. What you invest now with a pharmaceutical naming agency can save you time, money, and headaches later.